Project Grant R21DA061446

Award Date 9/1/24
Completion Date 8/31/26
Dollars Obligated $216K
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Maryland, USA
Similar Awards
This federal Project Grant award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to develop an integrative framework for measuring and understanding the functional roles of biomolecular condensates (BMCs) in olfactory neuron gene regulation. The award of $271,422 to the California Institute of Technology (Caltech) aims to define the spatial and molecular composition of BMCs, formulate neural network...
This $161,664 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support the development of a behavioral arena and computational framework to study social behaviors in Lake Malawi cichlids. The project aims to create tools to track animals and measure social behavioral dynamics within a natural environment mimicking context, including factors like hierarchy and male displays. This work will generate new...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $148,568 to the University of Florida to study the molecular arrangement of GABA(B) receptor-G protein-coupled inwardly rectifying potassium (GIRK) channel signaling pathways. The research aims to determine how these protein complexes interact and change configuration during drug-induced disruptions to inhibitory neurotransmission, with a focus...
This federal Project Grant award, provided by the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop methods for integrating large-scale electron microscopy (EM) brain imaging data with functional and behavioral recordings. The $1,100,864 project, spanning from September 30, 2024 to September 29, 2027, will focus on relating the structure and function of neural circuits in the Drosophila brain. The proposed research seeks to...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $455,940 to the University of Massachusetts Lowell to study the biophysical properties of intrinsically disordered proteins (IDPs) when confined to nanoscale environments. The research aims to reveal how the structural plasticity of IDPs is influenced by their localization and confinement on nanoparticle constructs, with the...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $399,536 to Chemregen Inc.'s Human Biomolecular Research Institute in San Diego, CA. The funding supports research to design, synthesize, and test non-opioid drug candidates as potential treatments for opioid use disorder and fentanyl toxicity. Key objectives include characterizing the effects of opioids on human induced pluripotent stem...
This $2.8 million project grant from the National Institutes of Health Office of the Director, under the Trans-NIH Research Support program (CFDA 93.310), will fund the development of multifunctional phase sensors to probe and manipulate intracellular biomolecular condensates in brain organoid models. Emory University, as the primary awardee, will engineer sensors encoded with ultra-weak multivalent interactions and fluorescent and catalytic domains to serve as multi-functional liquid-liquid...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $126,432 to the Regents of the University of Michigan to optimize chemical- and light-dependent protein switches for controlling opioid peptide activity with temporal control. The research aims to advance understanding of opioid receptor function and inform the development of safer pain management strategies, novel opioid medications, and...
This $284,040 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to conduct integrated single-cell and spatial mapping of the habenula circuitry to identify projection-specific molecular pathways associated with opioid exposure. The Lieber Institute for Brain Development in Baltimore, MD will lead this research effort from September 1, 2024 to August 31, 2026. The project will generate a...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $454,251 to The Trustees of the University of Pennsylvania to develop a novel "released markers of activity" (RMAs) blood-based monitoring system for long-term tracking of neural circuit activity and opioid receptor gene expression changes in mice exposed to opioids. The goal is to better understand the molecular and functional...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop a genetically encoded hydrophobicity biosensor to monitor the dynamic changes in hydrophobicity within biomolecular condensates in living cells. The $216,315 award, active from September 1, 2024, to August 31, 2026, will support the creation of a recombinant protein sensor that uses Förster resonance energy transfer (FRET) to report on hydrophobicity levels. The principal goal is to establish a calibration curve to quantify hydrophobicity and then demonstrate the sensor's ability to monitor changes in hydrophobicity within biomolecular condensates containing the protein paxillin, which is involved in neurite growth, cell migration, and endocytosis. If successful, the design principle could be applied to measure hydrophobicity of condensates containing other molecules, potentially advancing the understanding of how liquid-liquid phase separation regulates important cellular processes.

Generated 7/1/25, 5:53 AM